Wednesday, November 18, 2026 | Jumada al-akhirah 7, 1448 H
broken clouds
weather
OMAN
26°C / 26°C
EDITOR IN CHIEF- ABDULLAH BIN SALIM AL SHUEILI

US FDA authorizes Merck's at home antiviral COVID-19 pill

No Image
minus
plus

The US Food and Drug Administration on Thursday authorized Merck & Co's antiviral pill for COVID-19, after giving the go-ahead to a similar treatment from Pfizer Inc a day earlier.


Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness.


The agency authorized the oral drug for the treatment of mild-to-moderate COVID-19 in adults who are at risk for severe disease, and for whom alternative COVID-19 treatments are not accessible or clinically appropriate.


The US government has a contract to buy as many as 5 million courses of the drug for $700 per course.


The drug is not authorized for use in patients younger than 18 because molnupiravir may affect bone and cartilage growth, the FDA said in a statement. --Reuters


SHARE ARTICLE
Most Read
Hydrom launched the fourth round of public tenders for green energy projects dedicated to powering AI data centres
Oman signs two pacts for green hydrogen projects Rough sea, scattered rain expected in parts of Oman US-Oman venture plans aerospace industrial hub in Duqm Probation period cannot exceed three months for monthly-paid workers
FOLLOW US
arrow up
home icon